CD34(+) cells augment endothelial cell differentiation of CD14(+) endothelial progenitor cells in vitro

Neovascularization by endothelial progenitor cells (EPC) for the treatment of ischaemic diseases has been a topic of intense research. The CD34(+) cell is often designated as EPC, because it contributes to repair of ischaemic injuries through neovascularization. However, incorporation of CD34(+) cel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Cell Mol Med
Autores principales: Krenning, G., van der Strate, B.W.A., Schipper, M., van Seijen, X.J. Gallego y, Fernandes, B.C.A., van Luyn, M.J.A., Harmsen, M.C.
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Publishing Ltd 2008
Materias:
Tissue Regeneration
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512353/
https://ncbi.nlm.nih.gov/pubmed/18752636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1582-4934.2008.00479.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares